U.S. challenges ‘bogus’ drug patents
Published: May 1, 2024

WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic. It’s the latest...
Subscribe Today!
Advertisement